Michael B. Keller

Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 02, 2026

Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure.

Journal: Transplantation direct

Published: April 02, 2025

Early post-transplant recipient tissue injury predicts allograft function, rejection and survival in lung transplant recipients: evidence from cell-free DNA.

Journal: The European respiratory journal

Published: January 06, 2025

Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: December 20, 2024

Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: October 24, 2024

Comparison of Web-Based and On-Site Lung Simulators for Education in Mechanical Ventilation.

Journal: Respiratory care

Published: October 08, 2024

Reply to Glanville: The Emperor's New Clothes Revisited.

Journal: American journal of respiratory and critical care medicine

Published: August 21, 2024

Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.

Journal: Transplantation direct

Published: April 05, 2024

Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.

Journal: American journal of respiratory and critical care medicine

Published: January 08, 2024

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: January 02, 2024

Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.

Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.

Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure.

Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure.

Early post-transplant recipient tissue injury predicts allograft function, rejection and survival in lung transplant recipients: evidence from cell-free DNA.

Early post-transplant recipient tissue injury predicts allograft function, rejection and survival in lung transplant recipients: evidence from cell-free DNA.

Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.

Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.

Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.

Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.

Comparison of Web-Based and On-Site Lung Simulators for Education in Mechanical Ventilation.

Comparison of Web-Based and On-Site Lung Simulators for Education in Mechanical Ventilation.

Reply to Glanville: The Emperor's New Clothes Revisited.

Reply to Glanville: The Emperor's New Clothes Revisited.

Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.

Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.

Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.

Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.

Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.

Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates.

Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates.

Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19-Specific Severity Score.

Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19-Specific Severity Score.